Targeting PCSK9: Bioinformatics Analysis Reveals Functionally Damaging Missense Variants
Keywords:
bioinformatics, low density lipoprotein receptor (LDLR), proprotein convertase subtilisin/kexin type 9 (PCSK9), single nucleotide polymorphisms (SNPs), in silico analysisAbstract
Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis by targeting low-density lipoprotein receptor (LDLR) for lysosomal degradation. Genetic polymorphisms in PCSK9 can alter its autocatalytic processing, secretion, or binding affinity to LDLR. Reduce binding efficiency between PCSK9 and LDLR leads to elevated low-density lipoprotein cholesterol (LDL-C) level, thereby promoting atherosclerotic plaque formation and increasing the risk of ischemic stroke. The objective of this study was to identify the most functionally significant non-synonymous single-nucleotide polymorphisms (nsSNPs) in PCSK9 via an integrated in silico analysis combining functional prediction tools (PROVEAN, SIFT, PolyPhen-2, SNAP2), protein stability and disease-association predictors, ligand-binding assessment, and post-translational modification analysis. A total of 4,979 PCSK9 variants were retrieved from Ensembl GRCh37/hg19, and HGMD. Functional annotation using PROVEAN, SIFT, PolyPhen-2, and SNAP2 identified 253 nsSNPs, with PolyPhen-2 predicting the largest subset. Upon filtering through the protein stability, disease association, ligand binding, and post-translational modification, five nsSNPs (W156R, H226L, H229R, G337R, and G394V) emerged as the most deleterious, with potential to disrupt secondary autocatalytic processing and significantly impair LDLR-PCSK9 interactions. These findings highlight novel candidate variants that may serve as diagnostic biomarkers and therapeutic targets in dyslipidemia and cardiovascular disease.
Downloads
Metrics
References
Abifadel, M., Varret, M., Rabès, J.P., Allard, D., Ouguerram, K., Devillers, M. & Boileau, C. 2003. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nature Genetics, 34(2): 154-156. DOI: https://doi.org/10.1038/ng1161
Adzhubei, I., Jordan, D.M. & Sunyaev, S.R. 2013. Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics, 76(1): 7-20. DOI: https://doi.org/10.1002/0471142905.hg0720s76
Au, A. & Wei, L.K. 2017. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: evidence from a meta-analysis. Atherosclerosis, 265: 60-70. DOI: https://doi.org/10.1016/j.atherosclerosis.2017.08.003
Au, A., Griffiths, L.R., Cheng, K.K., Kooi, C.W., Irene, L. & Wei, L.K. 2015. The influence of OLR1 and PCSK9 gene polymorphisms on ischemic stroke: evidence from a meta-analysis. Scientific Reports, 5: 18224. DOI: https://doi.org/10.1038/srep18224
Benjannet, S., Hamelin, J., Chrétien, M. & Seidah, N.G. 2012. Loss-and gain-of-function PCSK9 variants cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation. Journal of Biological Chemistry, 287(40): 33745-33755. DOI: https://doi.org/10.1074/jbc.M112.399725
Boutet, E., Lieberherr, D., Tognolli, M., Schneider, M., Bansal, P., Bridge, A.J., ... & Xenarios, I. 2016. UniProtKB/Swiss-Prot, the manually annotated section of the UniProt KnowledgeBase: how to use the entry view. In: Plant Bioinformatics: Methods and Protocols, pp. 23-54. Springer, New York. DOI: https://doi.org/10.1007/978-1-4939-3167-5_2
Bromberg, Y. & Rost, B. 2007. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Research, 35(11): 3823-3835. DOI: https://doi.org/10.1093/nar/gkm238
Cameron, J., Holla, Ø.L., Laerdahl, J.K., Kulseth, M.A., Ranheim, T., Rognes, T. & Leren, T.P. 2008. Characterization of novel mutations in the catalytic domain of the PCSK9 gene. Journal of Internal Medicine, 263(4): 420-431. DOI: https://doi.org/10.1111/j.1365-2796.2007.01915.x
Capriotti, E. & Fariselli, P. 2017. PhD-SNPg: a webserver and lightweight tool for scoring single nucleotide variants. Nucleic Acids Research, 45(W1): W247-W252. DOI: https://doi.org/10.1093/nar/gkx369
Capriotti, E., Calabrese, R., Fariselli, P., Martelli, P.L., Altman, R.B. & Casadio, R. 2013. WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation. BMC Genomics, 14(3): S6. DOI: https://doi.org/10.1186/1471-2164-14-S3-S6
Chaudhary, R., Garg, J., Shah, N. & Sumner, A. 2017. PCSK9 inhibitors: a new era of lipid lowering therapy. World Journal of Cardiology, 9(2): 76-91. DOI: https://doi.org/10.4330/wjc.v9.i2.76
Cheng, J., Randall, A. & Baldi, P. 2006. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins: Structure, Function, and Bioinformatics, 62(4): 1125-1132. DOI: https://doi.org/10.1002/prot.20810
Choi, Y. & Chan, A.P. 2015. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 31(16): 2745-2747. DOI: https://doi.org/10.1093/bioinformatics/btv195
Chorba, J.S., Galvan, A.M. & Shokat, K.M. 2018. Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype. Journal of Biological Chemistry, 293(6): 1875-1886. DOI: https://doi.org/10.1074/jbc.RA117.000754
Deng, W., Wang, Y., Ma, L., Zhang, Y., Ullah, S. & Xue, Y. 2017. Computational prediction of methylation types of covalently modified lysine and arginine residues in proteins. Briefings in Bioinformatics, 18(4): 647-658. DOI: https://doi.org/10.1093/bib/bbw041
Ferrer-Costa, C., Gelpí, J.L., Zamakola, L., Parraga, I., De La Cruz, X. & Orozco, M. 2005. PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics, 21(14): 3176-3178. DOI: https://doi.org/10.1093/bioinformatics/bti486
Glaser, L. 1988. The biology and enzymology of eukaryotic protein acylation. Annual Review of Biochemistry, 57: 69-99. DOI: https://doi.org/10.1146/annurev.bi.57.070188.000441
Han, B.H., Sutin, D., Williamson, J.D., Davis, B.R., Piller, L.B., Pervin, H., Pressel, S.L. & Blaum, C.S. 2017. Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial. JAMA Internal Medicine, 177(7): 955-965. DOI: https://doi.org/10.1001/jamainternmed.2017.1442
Hu, J., Li, Y., Zhang, Y. & Yu, D.J. 2018. ATPbind: accurate protein–ATP binding site prediction by combining sequence-profiling and structure-based comparisons. Journal of Chemical Information and Modeling, 58(2): 501-510. DOI: https://doi.org/10.1021/acs.jcim.7b00397
Hulo, N., Bairoch, A., Bulliard, V., Cerutti, L., De Castro, E., Langendijk-Genevaux, P.S., ... & Sigrist, C.J. 2006. The PROSITE database. Nucleic Acids Research, 34(suppl_1): D227-D230. DOI: https://doi.org/10.1093/nar/gkj063
Howe, K. L., Achuthan, P., Allen, J., Allen, J., Alvarez-Jarreta, J., Amode, M. R., ... & Flicek, P. 2021. Ensembl 2021. Nucleic Acids Research, 49(D1): D884-D891. DOI: https://doi.org/10.1093/nar/gkaa942
Parthiban, V., Gromiha, M.M. & Schomburg, D. 2006. CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Research, 34(suppl_2): W239-W242. DOI: https://doi.org/10.1093/nar/gkl190
Pejaver, V., Hsu, W.L., Xin, F., Dunker, A.K., Uversky, V.N. & Radivojac, P. 2014. The structural and functional signatures of proteins that undergo multiple events of post-translational modification. Protein Science, 23(8): 1077-1093. DOI: https://doi.org/10.1002/pro.2494
Pejaver, V., Urresti, J., Lugo-Martinez, J., Pagel, K.A., Lin, G.N., Nam, H.J., Mort, M., Cooper, D.N., Sebat, J., Iakoucheva, L.M. & Mooney, S.D. 2017. MutPred2: inferring the molecular and phenotypic impact of amino acid variants. BioRxiv, 134981. DOI: https://doi.org/10.1101/134981
Peloso, G.M., Lange, L.A., Varga, T.V., Nickerson, D.A., Smith, J.D., Griswold, M.E., Musani, S., Polfus, L.M., Mei, H., Gabriel, S. & Quarells, R.C. 2016. Association of exome sequences with cardiovascular traits among blacks in the Jackson Heart Study. Circulation: Cardiovascular Genetics, 9(4): 368-374. DOI: https://doi.org/10.1161/CIRCGENETICS.116.001410
Peng, J. & Xu, J. 2011. RaptorX: exploiting structure information for protein alignment by statistical inference. Proteins: Structure, Function, and Bioinformatics, 79(S10): 161-171. DOI: https://doi.org/10.1002/prot.23175
Pires, D.E., Ascher, D.B. & Blundell, T.L. 2014. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Research, 42(W1): W314-W319. DOI: https://doi.org/10.1093/nar/gku411
Protein Data Bank. 1971. Protein Data Bank. Nature New Biology, 233(223): 10-1038. DOI: https://doi.org/10.1038/newbio233223b0
Stenson, P.D., Ball, E.V., Mort, M., Phillips, A.D., Shiel, J.A., Thomas, N.S., ... & Cooper, D.N. 2003. Human gene mutation database (HGMD®): 2003 update. Human Mutation, 21(6): 577-581. DOI: https://doi.org/10.1002/humu.10212
Thomas, P.D., Campbell, M.J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A. & Narechania, A. 2003. PANTHER: a library of protein families and subfamilies indexed by function. Genome Research, 13(9): 2129-2141. DOI: https://doi.org/10.1101/gr.772403
Udenwobele, D.I., Su, R.C., Good, S.V., Ball, T.B., Varma Shrivastav, S. & Shrivastav, A. 2017. Myristoylation: an important protein modification in the immune response. Frontiers in Immunology, 8: 751. DOI: https://doi.org/10.3389/fimmu.2017.00751
Vaser, R., Adusumalli, S., Leng, S.N., Sikic, M. & Ng, P.C. 2016. SIFT missense predictions for genomes. Nature Protocols, 11(1): 1-12. DOI: https://doi.org/10.1038/nprot.2015.123
Wang, L. & Sauer, U. 2010. Prediction of protein stability changes due to single amino acid mutations. BMC Bioinformatics, 11: 190. DOI: https://doi.org/10.1186/1471-2164-11-S2-S5
Weider, E., Susan-Resiga, D., Essalmani, R., Hamelin, J., Asselin, M.C., Nimesh, S., Ashraf, Y., Wycoff, K.L., Zhang, J., Prat, A. & Seidah, N.G. 2016. Proprotein convertase subtilisin/kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation. Journal of Biological Chemistry, 291(32): 16659-16671. DOI: https://doi.org/10.1074/jbc.M116.717736
Wheeler, D.L., Barrett, T., Benson, D.A., Bryant, S.H., Canese, K., Chetvernin, V., ... & Yaschenko, E. 2007. Database resources of the national center for biotechnology information. Nucleic Acids Research, 36(suppl_1): D13-D21. DOI: https://doi.org/10.1093/nar/gkm1000
Yang, J., Roy, A. & Zhang, Y. 2013. Protein–ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics, 29(20): 2588-2595. DOI: https://doi.org/10.1093/bioinformatics/btt447
Zhang, C., Freddolino, P.L. & Zhang, Y. 2017. COFACTOR: improved protein function prediction by combining structure, sequence and protein–protein interaction information. Nucleic Acids Research, 45(W1): W291-W299. DOI: https://doi.org/10.1093/nar/gkx366
Zhang, L., Deng, T., Pan, S., Zhang, M., Zhang, Y., Yang, C., ... & Mi, J. 2024. DeepO-GlcNAc: A web server for prediction of protein O-GlcNAcylation sites using deep learning combined with attention mechanism. Frontiers in Cell and Developmental Biology, 12: 1456728. DOI: https://doi.org/10.3389/fcell.2024.1456728
Zhang, Y., Ultsch, M., Skelton, N.J., Burdick, D.J., Beresini, M.H., Li, W., Kong-Beltran, M., Peterson, A., Quinn, J., Chiu, C. & Wu, Y. 2017. Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists. Nature Structural & Molecular Biology, 24(10): 848-856. DOI: https://doi.org/10.1038/nsmb.3453
Zhou, F., Xue, Y., Yao, X. & Xu, Y. 2006. CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics, 22(7): 894-896. DOI: https://doi.org/10.1093/bioinformatics/btl013
Published
How to Cite
Issue
Section
Any reproduction of figures, tables and illustrations must obtain written permission from the Chief Editor (wicki@ukm.edu.my). No part of the journal may be reproduced without the editor’s permission











